Test Price
2,800 AED✅ Home Collection Available
SLC4A1 Gene Ovalocytosis Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO‑certified NGS processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (available daily 8 AM to 11 PM).
- Clinical Guidance: Complimentary telephonic post‑test clinical interpretation support by our Consultant Medical Genetics.
- Insurance: Direct Billing Verification via WhatsApp – message +971 54 548 8731 with your policy card.
Test Overview & Methodology
The SLC4A1 Gene Ovalocytosis Genetic Test analyses the entire coding region of the SLC4A1 gene using Next Generation Sequencing to detect pathogenic variants responsible for hereditary ovalocytosis (Southeast Asian ovalocytosis) and related erythrocyte membrane defects. This comprehensive analysis covers all exons, splice sites, and known deep intronic regions, providing a definitive molecular diagnosis.
| Feature | Our Test (NGS Full‑Gene Sequencing) | Closest Alternative (Targeted PCR) |
|---|---|---|
| Precision | 99.9% analytical sensitivity; covers all exons, splice sites, and known deep intronic variants | Limited to selected hot‑spot mutations; may miss rare or novel pathogenic alterations |
| Methodology | Next Generation Sequencing (Illumina® platform) with bioinformatic verification | Allele‑specific PCR or Sanger sequencing (restricted regions) |
| Speed | Definitive report in 3–4 weeks from sample receipt | 2–3 weeks for common mutations, reflex to full gene adds 4+ weeks |
| Clinical Value | Comprehensive for diagnosis, family screening, and pre‑conception counselling | Adequate only when family mutation is already known |
Physician Insight & Safety Protocols
“The SLC4A1 gene encodes a critical anion exchanger in red blood cells. A precise genetic diagnosis not only confirms ovalocytosis but also guides management of associated hemolytic risks and informs family planning. Every test result should be reviewed alongside a complete blood count, reticulocyte count, and family history. I encourage patients to schedule a follow‑up genetic counselling session to fully understand their report.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Advisory: Medication & Lifestyle Precautions
⚕️ Medication Warning
Do not discontinue any prescribed medication or supplement without explicit instruction from your doctor. This test evaluates inherited genetic changes and has no immediate bearing on your current therapeutic regimen. Genetic test results may occasionally suggest avoiding certain drugs (e.g., oxidant stress triggers), but any changes must be managed by your treating physician.
Safety Box – Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Inability to provide informed consent; active severe hemolytic crisis requiring urgent medical stabilization; known interfering bone marrow transplantation within the last 90 days.
- Red Flags (Seek Immediate Emergency Care): Sudden dark urine, jaundice with fever, chest pain or shortness of breath, rapid fall in hemoglobin (pallor, syncope). These may indicate acute hemolysis unrelated to the test itself.
- Home Collection Safety: Our phlebotomists are trained to recognise acute distress; if you feel unwell before the appointment, reschedule and contact your nearest emergency department.
Patient FAQ & Clinical Guidance
1. What does the SLC4A1 genetic test actually detect?
This test identifies pathogenic DNA variants in the SLC4A1 gene that cause hereditary ovalocytosis, a condition that alters red blood cell shape and may lead to mild hemolysis or resistance to certain malaria. The analysis covers the complete coding sequence and adjacent splice regions, providing a definitive molecular diagnosis for patients with suggestive blood film or clinical symptoms.
2. How should I prepare for the blood draw, and is home collection safe?
No fasting or special preparation is required; simply hydrate well and keep your arm warm to aid vein visibility. Our VIP Mobile Phlebotomy service uses ISO‑certified cold‑chain transport and a trained phlebotomist arrives with full PPE, ensuring sample stability and your safety.
3. Will my health insurance cover the 2800 AED cost?
Many UAE insurers partially or fully reimburse hereditary ovalocytosis NGS testing when medically indicated; we verify coverage in real time via WhatsApp. Send your insurance card to +971 54 548 8731 and our billing team will confirm your eligible amount before collection.
4. What turnaround time can I expect for results?
The full-gene sequencing process typically requires 3–4 weeks from the date of sample receipt. A preliminary verbal report may be available earlier if clinically urgent. You will receive a detailed PDF report with variant classifications and clinical recommendations.
UAE Regulatory & Data Privacy Adherence
This genetic testing service operates in full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data is encrypted and stored exclusively in UAE‑based, DHA‑licensed cloud servers. You retain full rights to access, rectify, or delete your genetic information.
Clinical testing safety and patient consent adhere to Federal Decree‑Law No. 4 of 2016 on Medical Liability. Our laboratory is ISO 9001:2015 certified (Certificate No. INT/EGQ/2509DA/3139) and operates under DHA Facility License 1143.
Clinical & Logistical Metadata
| Test Name | SLC4A1 Gene Ovalocytosis Genetic Test (NGS Full‑Gene Sequencing) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole Blood (EDTA) – Standard peripheral venipuncture. VIP Mobile Phlebotomy home collection available daily 8 AM to 11 PM. |
| Methodology Used | Next Generation Sequencing (Illumina® platform), full‑gene sequencing covering all exons and splice sites |
| ICD-10-CM Code | D58.2 (Other hereditary hemolytic anemias, ovalocytosis) |
| LOINC Code | 93145-6 (SLC4A1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method) |
| DHA Facility License & Address | Facility License 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians